Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
bit.bio
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our…
bit.bio
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our…
TL;DR
Headquarters / Origin: Cambridge, UK; spun out of the University of Cambridge in 2016
Core technology: opti-ox™ platform for deterministic programming of human iPSCs
Product lines: ioCells (preprogrammed human cells for research) and pipeline for txCells (therapeutics)
Recent funding signal: Multiple venture rounds; reported ~US$225M raised with rounds including $41.5M (2020), $103M Series B (2021), and a Dec 2024 financing
Approximately 174 employees
